The project investigates whether whale oil can help reduce gut inflammation and pave the way for new, evidence‑based health‑promoting products for people with inflammatory bowel disease (IBD).
Inflammatory bowel disease is a chronic condition that often develops early in life and requires long‑term treatment. Research shows that diet and fatty acid composition can influence disease progression, and marine omega‑3 fatty acids are well known for their anti‑inflammatory properties.
Whale oil differs from other marine oils by its high content of the fatty acid DPA, which plays an important role in regulating the body’s omega‑3 balance. Previous studies suggest that whale oil may have a stronger anti‑inflammatory effect than traditional fish oil. In this project, Møreforsking, in collaboration with Myklebust Hvalprodukter, will examine the effects of whale oil on human intestinal cell lines to assess whether the oil can protect against inflammation and potentially enhance the effects of existing IBD medications.
The project will also evaluate how production and storage conditions influence the quality and biological activity of the oil. The aim is to develop solid scientific documentation to support new, sustainable health products based on marine raw materials.
Do you want to collaborate with Møreforsking, or do you have questions about our publications or projects? Feel free to contact us, we are happy to help you find the solution that best meets your needs. Our researchers offer broad expertise and extensive experience across a wide range of marine disciplines.